Revenue and profit declined year-over-year in H1 2024, with sales at ₩52.6B and net income at ₩7.1B. The company completed a major share buyback and maintains a strong balance sheet, focusing on R&D and future business diversification.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.